Chief Executive Officer (CEO) of Biogen and a member of its Board of Directors since January 2017. Joined the company in 2016 as Executive Vice-President, Chief Commercial Officer. Biogen is pursuing its strategy as a leader in neuroscience as well as adjacent therapeutic areas, underpinned by the belief that neurological diseases and treatment strategies are interconnected. Prior to joining Biogen, had a 20-year career at Merck and has additionally held management positions at Ciba-Geigy. CSCT certificate in Medicine from the Université Victor Segalen, Bordeaux II, France; MBA from the HEC School of Management in Paris.